WallStreetZenWallStreetZen

NASDAQ: ERNA
Eterna Therapeutics Inc Stock

$0.95-0.05 (-5%)
Updated Oct 3, 2024
ERNA Price
$0.95
Fair Value Price
N/A
Market Cap
$5.14M
52 Week Low
$0.84
52 Week High
$2.63
P/E
-0.21x
P/B
-0.6x
P/S
61.11x
PEG
N/A
Dividend Yield
N/A
Revenue
$162.00k
Earnings
-$23.92M
Gross Margin
-111.1%
Operating Margin
-13,412.35%
Profit Margin
-14,775.3%
Debt to Equity
-6.45
Operating Cash Flow
-$16M
Beta
0.94
Next Earnings
Nov 11, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ERNA Overview

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.

Zen Score

–
Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ERNA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ERNA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ERNA is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
ERNA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more ERNA due diligence checks available for Premium users.

Be the first to know about important ERNA news, forecast changes, insider trades & much more!

Valuation

ERNA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.21x
Industry
-109.51x
Market
26.22x

ERNA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-0.6x
Industry
5.92x

ERNA's financial health

Profit margin

Revenue
$47.0k
Net Income
-$5.5M
Profit Margin
-11,780.9%
ERNA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ERNA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$46.5M
Liabilities
$55.0M
Debt to equity
-6.45
ERNA's short-term liabilities ($9.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ERNA's long-term liabilities ($45.41M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ERNA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ERNA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.3M
Investing
-$249.0k
Financing
-$22.0k
ERNA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ERNA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ERNA$5.14M-4.62%-0.21x-0.60x
CDIO$5.15M-6.52%-0.51x1.67x
BNOX$5.20M-14.72%-0.22x0.43x
VRAX$5.02M+5.41%-0.58x0.94x
HOTH$5.39M-5.68%-0.49x0.58x

Eterna Therapeutics Stock FAQ

What is Eterna Therapeutics's quote symbol?

(NASDAQ: ERNA) Eterna Therapeutics trades on the NASDAQ under the ticker symbol ERNA. Eterna Therapeutics stock quotes can also be displayed as NASDAQ: ERNA.

If you're new to stock investing, here's how to buy Eterna Therapeutics stock.

What is the 52 week high and low for Eterna Therapeutics (NASDAQ: ERNA)?

(NASDAQ: ERNA) Eterna Therapeutics's 52-week high was $2.63, and its 52-week low was $0.84. It is currently -63.81% from its 52-week high and 13.1% from its 52-week low.

How much is Eterna Therapeutics stock worth today?

(NASDAQ: ERNA) Eterna Therapeutics currently has 5,410,588 outstanding shares. With Eterna Therapeutics stock trading at $0.95 per share, the total value of Eterna Therapeutics stock (market capitalization) is $5.14M.

Eterna Therapeutics stock was originally listed at a price of $2,000.00 in Dec 31, 1997. If you had invested in Eterna Therapeutics stock at $2,000.00, your return over the last 26 years would have been -99.95%, for an annualized return of -25.5% (not including any dividends or dividend reinvestments).

How much is Eterna Therapeutics's stock price per share?

(NASDAQ: ERNA) Eterna Therapeutics stock price per share is $0.95 today (as of Oct 3, 2024).

What is Eterna Therapeutics's Market Cap?

(NASDAQ: ERNA) Eterna Therapeutics's market cap is $5.14M, as of Oct 4, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Eterna Therapeutics's market cap is calculated by multiplying ERNA's current stock price of $0.95 by ERNA's total outstanding shares of 5,410,588.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.